Society of Pharmaceutical Sciences and Research

One-Day International Conference

Society of Pharmaceutical Sciences and Research (SPSR), in collaboration with Gurukula Kangri (Deemed to be University), Haridwar, invites you to participate.

📅 31 January 2026 (Saturday)
📍 Venue: Gurukula Kangri (DU), Haridwar
🎯 Theme:
Research, Development & Innovation in Healthcare, Technology, Biological & Pharmaceutical Sciences for Viksit Bharat–2047

Why Attend?
* Latest research & innovations
* Interdisciplinary learning
* Networking with experts
* Global academic exposure

🤝 Organized by: Gurukula Kangri (DU) In collaboration with: Society of Pharmaceutical Sciences and Research (SPSR)

📢 Join us to learn, collaborate & innovate for a developed India 👇🏻

🔗 tinyurl.com/35m7fehn

9 hours ago | [YT] | 4

Society of Pharmaceutical Sciences and Research

3rd International Conference Announcement

Shri Shankaracharya College of Pharmaceutical Sciences (SSCPS), SSPU, Bhilai (C.G.)
in collaboration with Society of Pharmaceutical Sciences and Research (SPSR)

Theme: Green Biotechnology & Artificial Intelligence
🗓 Dates: 21–22 January 2026

🔹 Explore sustainable innovations in biotechnology
🔹 Learn how AI is transforming pharmaceutical research
🔹 Hear from eminent academicians & industry experts
🔹 Network with researchers, professionals & students
🔹 Opportunities for learning, collaboration & growth

📌 Save the dates!

Register here:👇🏻

🔗 tinyurl.com/4anypb5c

2 days ago | [YT] | 8

Society of Pharmaceutical Sciences and Research

Struggling with long research PDFs?

What if you could talk to your papers instead of reading them line by line?

There are AI tools that let you:

✅ Ask questions directly from PDFs
✅ Get instant summaries
✅ Extract key insights in plain language

Perfect for:

🎓 Students
🔬 Researchers
👩‍🏫 Faculty & mentors

Here is a post explaining how this works + the best tools to use.

👉 Check it out here: tinyurl.com/4tejbez3

Save time.
Ask better questions.
Make research easier.

3 days ago | [YT] | 2

Society of Pharmaceutical Sciences and Research

International Conference Alert!

ICAR-APRPB 2026
AI-Powered Revolution in Pharmaceutical & Biological Sciences

Organized by SPSR in collaboration with Axis Institute of Pharmacy, Axis Colleges, Kanpur

📅 21–22 Feb 2026 | 🌐 Hybrid Mode

Highlights:
* Keynote talks by national & international experts
* Paper & poster presentations
* AI-driven innovations & product exhibitions
* Awards, certificates & networking opportunities

📝 Abstract & Registration Deadline: 15 January 2026

👉🏻 Register Now 👇🏻
🔗tinyurl.com/2zmft2ax

Be part of the AI-driven future of Pharmaceutical & Biological Sciences. Share with your colleagues & students.

Explore how Artificial Intelligence is transforming drug discovery, pharmaceutical research, biology & healthcare

4 days ago | [YT] | 9

Society of Pharmaceutical Sciences and Research

New researchers, read this before you submit

Most papers don’t fail at peer review.
They get filtered before it.

This post explains:
* What editors check first
* Why desk rejections happen
* How clarity moves your paper forward

👉 Read here: tinyurl.com/4d23jvnb

5 minutes now can save you months later. ♻️ Share with anyone submitting their first paper.

5 days ago | [YT] | 0

Society of Pharmaceutical Sciences and Research

December FDA Drug Approvals: New Hope Across Cardiology, Oncology & Rare Diseases

The FDA has delivered another wave of impactful drug approvals that promise to reshape care across multiple therapeutic areas. From rare disease to oncology and cardiology, here’s a roundup of notable December approvals:

Key FDA New Drug Approvals & Indications:

▪️Yartemlea: Approved for hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and pediatric patients ≥2 years, offering a targeted option for a life-threatening post-transplant complication.

▪️Aqvesme: A pyruvate kinase activator indicated for the treatment of anemia in adults with alpha- or beta-thalassemia, providing a novel mechanism to address chronic hemolytic anemia.

▪️ Myqorzo: Approved for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms in adults with this challenging cardiac condition.

▪️ Rybrevant Faspro: Now available as a subcutaneous therapy for EGFR-mutated non-small cell lung cancer (NSCLC). This first-of-its-kind formulation across all amivantamab indications enables quicker, less invasive administration with consistent efficacy.

▪️ Fesilty: A purified human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, helping address a critical hemostatic need.

December’s FDA approvals underscore a powerful trend:

Novel therapies are increasingly tackling complex and underserved conditions with precision and patient-centered delivery. From rare transplant-related complications to tailored oncology and cardiology advances, these approvals not only extend treatment options but also enhance quality of life for patients across diverse care settings.

A promising start to the next chapter of pharmaceutical innovation.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) — become a member today.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖

1 week ago | [YT] | 9

Society of Pharmaceutical Sciences and Research

FDA December New Drug Approvals Spotlight: Exdensur (depemokimab-ulaa) Injection

"Severe Eosinophilic Asthma: Looking Beyond Inhalers"

Asthma isn’t always “just asthma.”

For many patients, eosinophilic inflammation drives frequent exacerbations, hospital visits, and poor disease control.

🔍 Why this matters:

▪️Severe eosinophilic asthma is fueled by Type-2 inflammation
▪️Eosinophils narrow airways, thicken walls, and worsen breathing
▪️Conventional therapies may not adequately address the root cause

What science shows:

▪️Targeting the IL-5 pathway can significantly reduce eosinophil levels
▪️Fewer exacerbations and reduced hospitalizations are achievable outcomes
▪️Long-acting biologic therapies are reshaping severe asthma management

Swipe through the infographic to:

✔ Understand what happens inside the asthmatic airway
✔ See how eosinophils drive disease severity
✔ Explore why targeted approaches matter in severe asthma care

If you found this insightful, like, share, and pass it along to colleagues and healthcare professionals in your network because awareness leads to better outcomes.


➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖➖ ➖ ➖
Elevate your professional journey with Society of Pharmaceutical Sciences and Research (SPSR) — become a member today.

🔗 spsrpharma.org/become-a-member
➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖➖ ➖ ➖

Skip the Carousel

1 2

1 week ago | [YT] | 17

Society of Pharmaceutical Sciences and Research

Why papers get rejected (from the Editor’s Desk)

Most manuscripts don’t fail because of poor English. They’re about misaligned thinking before submission. The F.A.I.L.S. framework is especially useful before submitting a manuscript.

Worth a quick read and saving if you’re working on a paper or guiding students. 👇🏻

🔗 tinyurl.com/y3e4huhw

2 weeks ago | [YT] | 3

Society of Pharmaceutical Sciences and Research

FDA December New Drug Approvals "Nuzolvence (Zoliflodacin)": A Breakthrough in Gonorrhea Treatment

Antimicrobial resistance continues to challenge global healthcare but innovation is paving the way forward.

Nuzolvence (zoliflodacin) is a first-in-class spiropyrimidinetrione antibiotic developed for the treatment of uncomplicated urogenital gonorrhea. By targeting bacterial type II topoisomerases, it introduces a novel mechanism of action distinct from existing therapies.

Why it matters:

▪️Addresses drug-resistant Neisseria gonorrhoeae
▪️Single-dose oral therapy improves patient compliance
▪️Represents a major advancement in STI management and AMR control

As resistance to current treatments rises, innovations like zoliflodacin highlight the critical role of next-generation antibiotics in safeguarding public health.

Explore the science behind this promising therapy and its potential impact on future gonorrhea treatment strategies.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖
Elevate your professional journey with Society of Pharmaceutical Sciences and Research - SPSR — become a member today.

➖ ➖ ➖ ➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖ ➖➖ ➖

2 weeks ago | [YT] | 8

Society of Pharmaceutical Sciences and Research

An abstract is the first thing reviewers see and often the only thing they read carefully before deciding. If it’s clear, specific, and data-led, the paper feels worth their time. If it’s vague, it feels risky.

Here’s a simple 5-part checklist (with AI tools and where to use them) to make an abstract stronger and more acceptance-ready.

If anyone is working on a paper, please take a minute to read it, might save you a lot of edits later. If it’s useful, feel free to share it with a friend/colleague.👇🏻

🔗 tinyurl.com/49fk6mjj

2 weeks ago | [YT] | 2